(Circulation. 2005;111:1946-1953.)
© 2005 American Heart Association, Inc.
Molecular Cardiology |
From the Departments of Internal Medicine (R.M., V.M., M.C., M.L.H., D.L., P.S., R.L., M.F.) and Biopathology and Diagnostic Imaging (A.M.), University of Rome Tor Vergata, and Center for Atherosclerosis (D.L., P.S., R.L., M.F.), Policlinico Tor VergataPTV University Hospital, Rome, Italy.
Correspondence to Dr Massimo Federici or Dr Renato Lauro, Department of Internal Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. E-mail federicm{at}uniroma2.it
Received October 21, 2004; revision received December 29, 2004; accepted January 11, 2005.
Background Obesity-related inflammation is emerging as a major cause of insulin resistance and cardiovascular diseases. GATA2 transcription factor is an inhibitor of adipogenesis and an activator of vascular cells. We hypothesized that GATA2 activity is controlled by insulin during adipogenesis, linking metabolic homeostasis and inflammation.
Methods and Results We show that insulin induces GATA2 phosphorylation on serine 401 in a PI-3K/Aktdependent manner. Insulin-dependent phosphorylation of serine 401 impairs GATA2 translocation to the nucleus and its DNA binding activity. A GATA2 mutant not phosphorylable by Akt (GATA2S401A) acts similarly to wild-type GATA2. In contrast, a GATA2 mutant that mimics Akt phosphorylation (GATA2S401D) is restrained in the cytoplasm. Cultured preadipocytes bearing GATA2S401A do not convert to adipocytes and express high levels of inflammatory cytokines like monocyte chemotactic protein-1 (MCP-1). On the contrary, GATA2S401D preadipocytes differentiate to adipocytes. When GATA2S401A preadipocytes are injected in mice fed a high-fat diet, they do not differentiate adequately into adipocytes, maintaining the expression of inflammatory markers like MCP-1. In contrast, injection of GATA2S401D preadipocytes in mice fed a high-fat diet results in development of adipocytes and no expression of inflammatory markers.
Conclusions GATA2 could be a new target in the prevention and treatment of obesity-related inflammation and its complications.
Key Words: diabetes mellitus inflammation insulin obesity signal transduction
This article has been cited by other articles:
![]() |
A. Shah, N. Mehta, and M. P. Reilly Adipose Inflammation, Insulin Resistance, and Cardiovascular Disease JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2276 - 2283. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |